Valuation: Simulations Plus, Inc.

Market Cap 37Cr 32Cr 30Cr 28Cr 53Cr 3.54TCr 54Cr 358.36Cr 139.29Cr 1.74TCr 139.51Cr 136.47Cr 5.99TCr P/E 2026 *
44x
P/E 2027 * 40.6x
Enterprise Value 37Cr 32Cr 30Cr 28Cr 53Cr 3.54TCr 54Cr 358.36Cr 139.29Cr 1.74TCr 139.51Cr 136.47Cr 5.99TCr EV / Sales 2026 *
4.55x
EV / Sales 2027 * 4.31x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day+0.22%
1 week+1.04%
Current month+0.44%
1 month+13.73%
3 months+53.38%
6 months+1.55%
Current year+0.88%
1 week 18.16
Extreme 18.16
18.68
1 month 15.64
Extreme 15.64
18.68
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 7.42
Extreme 7.4201
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
16/06Fiscal year

Executive/Senior Manager

22,050 0.1094%
15/06Fiscal year

Executive/Senior Manager

3,150 0.0156%
03/06Sell

Executive/Senior Manager

-1,000 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%+1.04%+3.61%-58.36% 37Cr
+4.62%+12.48%-32.20%-1.88% 3.13TCr
+1.81%+11.00%-31.80%+218.57% 1.52TCr
+0.48%+8.04%-15.44%+69.22% 590.9Cr
-8.94%-21.56% - - 241.17Cr
+5.52%+5.71% - - 223.18Cr
+2.62%+7.23%+44.20%-41.02% 195.7Cr
-8.30%-6.27%-29.07% - 114.12Cr
-0.34%+10.77%-33.12%+258.64% 83Cr
-5.71%+3.77%+560.00%+1,037.93% 76Cr
Average -0.80%+4.54%+58.27%+211.87% 621.04Cr
Weighted average by Cap. +2.53%+14.31%-19.69%+81.09%

Financials

2026 *2027 *
Net sales 8.17Cr 7.15Cr 6.56Cr 6.12Cr 12Cr 777.84Cr 12Cr 79Cr 31Cr 382Cr 31Cr 30Cr 1.32TCr 8.62Cr 7.54Cr 6.92Cr 6.46Cr 12Cr 820.59Cr 12Cr 83Cr 32Cr 402.99Cr 32Cr 32Cr 1.39TCr
Net income 90.22L 78.91L 72.42L 67.61L 1.28Cr 86Cr 1.3Cr 8.7Cr 3.38Cr 42Cr 3.39Cr 3.31Cr 145.57Cr 97.09L 84.92L 77.94L 72.75L 1.38Cr 92Cr 1.4Cr 9.36Cr 3.64Cr 45Cr 3.65Cr 3.57Cr 156.65Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
02/26/02 $18.39 +0.22% 4,83,048
01/26/01 $18.35 +0.22% 3,59,532
30/26/30 $18.31 -0.38% 8,72,617
29/26/29 $18.38 +0.99% 6,60,870
26/26/26 $18.20 +0.33% 11,62,293
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.39USD
Average target price
17.25USD
Spread / Average Target
-6.20%

Quarterly revenue - Rate of surprise